Paranthaman Senthamaraikannan

FDA investigator

Appears on 6 documents from 2022 to 2025, most often at sites in Ohio. Most often cites production record review (21 CFR 211.192).

6
Documents on file
3.8
Observations per 483
2022
First seen
2025
Most recent

What they cite most

From 23 observations

Activity by year

2022: 1, 2024: 4, 2025: 1

Where

Ohio 2 · Australia 1 · India 1 · Indiana 1 · Kentucky 1

Is Paranthaman Senthamaraikannan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 ARNA Pharma Pty,, LtdOct 17, 2025 · Frenchs Forest, Australia
483 Avantor Performance Materials LLCNov 13, 2024 · Paris, Kentucky
483 Oakwood Laboratories, L.L.C.Aug 13, 2024 · Solon, Ohio
483 AXXELENT PHARMA SCIENCE PRIVATE LIMITEDJun 21, 2024 · Sri City, India
483 Tenda Horse Products LLCMay 17, 2024 · Sandusky, Ohio
483 Lannett Company, Inc.Oct 21, 2022 · Seymour, Indiana

About this profile

What does Paranthaman Senthamaraikannan inspect?

Paranthaman Senthamaraikannan appears on 6 documents on file covering 6 sites, most often in Ohio.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Paranthaman Senthamaraikannan is dated Oct 17, 2025.